FDA 483 - Kedplasma LLC - January 26, 2023

An FDA inspection of BFL Plasma, Inc. in Phoenix, AZ, from January 24-26, 2023, revealed a significant failure in determining donor suitability. Specifically, the firm allowed at least two donors to donate blood components despite incomplete health assessments, indicating a lapse in proper screening procedures and record-keeping.